With an increasingly promising roster of approved cell therapies still burdened by complex manufacturing, multiple companies ...

Under the agreement, Cellares will use its Cell Shuttle and Cell Q systems to automate TSC-101 manufacturing processes.

Industries all over the world are being changed by the rise of automatic manufacturing jobs. Automation is supposed to make things more efficient and productive. But it also comes with its problems.

Lyell Immunopharma will evaluate Cellares’ automated manufacturing platform, the Cell Shuttle™, through Cellares’ Technology Adoption Partnership (TAP) program. As part of the collaboration, the ...

Current cell and gene manufacturing needs to catch up fast to help make the next wave of products at scale. (LuckyStep48/Getty Images) Where some gene therapy players might “go big” and put down brick ...

Cellares and TScan Therapeutics Announce Agreement to Evaluate Automated Manufacturing of TSC-101 for Patients with ...

CHICAGO--(BUSINESS WIRE)--CORE Industrial Partners LLC (“CORE”), a Chicago-based private equity firm, announced today the acquisition of CGI Automated Manufacturing (“CGI” or the “Company”), a custom ...

Cell therapies are in the process of revolutionizing the medical field. Last February, a pioneer of cell therapy, Carl June, reported that the second patient to ever receive a chimeric antigen ...

The advanced air mobility (AAM) market is gaining traction to transform the transportation of goods and people. While OEMs have focused on design and certification, supply chains have been left to ...

Opinions expressed by Entrepreneur contributors are their own. I recently took part in The EMS (Eric Miscoll Show), a biweekly panel discussion exploring all things manufacturing, and perhaps more ...